Roche unveils first data for new type of cancer immunotherapy

Roche is betting a new type of cancer immunotherapy could help to improve on the benefit offered by the first generation of immune-boosting drugs.

https://www.biopharmadive.com/news/roche-first-tigit-data-asco-tiragolumab/577897/

Leave a comment



Leave a Reply

Your email address will not be published. Required fields are marked *